Transcriptome sequencing demonstrated that KPNB1 could regulate the expression of NLGN3, which has been previously reported as a postsynaptic membrane protein that is highly expressed in the central nervous system and key to glioma progression. The gene discussed is KPNB1; the disease is glioma.